• Syringin Enhances Sunitinib Activity in Renal Cancer

  2026-09-17

  The reference study identifies syringin as a potential sensitizer that strengthens Sunitinib activity in renal cell carcinoma through modulation of the EGFR/PI3K/Akt pathway. By combining network pharmacology, molecular docking, and cell-based validation, the work proposes a natural-product strategy for addressing reduced Sunitinib responsiveness while highlighting the need for further in vivo and mechanistic validation.

• NSP2–MYB40 Controls Flavonoids and Symbiosis

  2026-09-16

  Gao et al. identify an NSP2–MYB40 transcriptional module that links flavonoid biosynthesis with rhizobial nodulation and arbuscular mycorrhizal colonization in Medicago truncatula. The study provides a mechanistic framework for understanding how plants adjust chemical signaling and nutrient acquisition under changing environmental conditions.

• HyperFusion™ High-Fidelity DNA Polymerase Guide

  2026-09-16

  Learn how HyperFusion high-fidelity DNA polymerase supports accurate PCR assay design for C. elegans neurodegeneration studies. This guide connects pheromone-driven neurodevelopmental mechanisms with error control, difficult-template amplification, and evidence-aware sequencing workflows.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-09-15

  The reference study provides direct perturbational evidence that cytoskeletal organization influences autophagy triggered by cellular compression. Its experiments identify microfilaments as a central structural requirement, while assigning microtubules an auxiliary role, offering a practical framework for studying mechanotransduction and stress-dependent autophagy.

• GPR35–KLF5 Control of Intestinal Repair

  2026-09-15

  A 2026 Cell Death and Disease study identifies a tryptophan–kynurenine–kynurenic acid sensing system in which GPR35 detects mucosal damage and signals through KLF5 and PI3K–AKT–mTOR to coordinate epithelial proliferation and migration. The findings provide a mechanistic framework for interpreting repair failure in ulcerative colitis and for designing intestinal inflammation models that distinguish tissue injury from regenerative responses.

• Tetracycline Workflows for Selection and Ribosome Studies

  2026-09-14

  Tetracycline combines broad-spectrum bacterial selection with a defined ribosome-centered mechanism that supports practical translation, growth, and membrane-integrity assays. This workflow shows how to prepare C6589 reproducibly, optimize selection without excessive background, and use it responsibly alongside lung adenocarcinoma research workflows inspired by LKB1–telomerase biology.

• PEGylated Iron Oxide Nanoparticles in the Liver

  2026-09-14

  This ACS Nano study separates the effects of iron oxide nanoparticle size and PEG chain length on hepatic biodistribution and cellular uptake. By combining 99mTc-SPECT/CT with primary liver-cell models, it shows that hepatocytes and stellate cells can contribute substantially to uptake, while 2K PEG provides the lowest hepatic accumulation among the tested formulations.

• WAY-100635 in 5-HT1A Pain Circuit Research

  2026-09-13

  WAY-100635 enables selective interrogation of 5-HT1A signaling across receptor-binding, functional, behavioral, and imaging workflows. Its use alongside a 2026 cannabidiol pain study helps separate serotonergic contributions from cannabinoid mechanisms without overstating what the evidence proves.

• From Sialylation Biology to Biotin Detection

  2026-09-12

  A thought-leadership guide connecting ST3GAL1-driven sialylation and Fusobacterium nucleatum adhesion in colorectal cancer with rigorous fluorescent assay design using Streptavidin-FITC.

• From Glucose Flux to Ferroptosis-Resistant HCC

  2026-09-11

  A translational framework for using fluorescent glucose uptake measurements to refine hepatocellular carcinoma resistance studies, while connecting glucose transport phenotypes with the lipid-remodeling and ferroptosis mechanisms reported for HNF4A-AS1.

• XAV-939: Tankyrase Inhibition in Wnt Research

  2026-09-11

  XAV-939, also called NVP-XAV939, is a cell-permeable tankyrase 1 and 2 inhibitor that stabilizes axin and suppresses β-catenin signaling. Its documented research applications include cancer research, fibrotic disease research, osteogenic differentiation, and bone formation disorder studies.

• MDV3100: Rethinking AR Therapy Responses

  2026-09-10

  MDV3100 (Enzalutamide) is more than a benchmark AR antagonist: it is a strategic tool for separating androgen receptor pathway blockade, apoptosis, and reversible senescence-like responses in prostate cancer models.

• Exemestane: From Aromatase Mechanism to Translation

  2026-09-10

  A translational framework for using Exemestane as a steroidal aromatase inhibitor in breast cancer research, combining irreversible target engagement, hormone measurements, biomarker context, and strategic comparison with receptor-directed endocrine approaches.

• Eltanexor Modulates Wnt/β-Catenin in Colorectal Cancer

  2026-09-09

  A 2024 bioRxiv preprint identifies XPO1 inhibition with Eltanexor (KPT-8602) as a potential chemopreventive strategy in colorectal cancer. The study connects nuclear retention of FoxO3a with reduced β-catenin/TCF activity, lower COX-2 expression, and decreased tumor burden in an Apcmin/+ mouse model.

• Tacalcitol Monohydrate: Assay Design Guide

  2026-09-09

  Tacalcitol monohydrate is a synthetic analog of vitamin D3 with applications spanning keratinocyte biology, NGF induction, and colorectal cancer research. This guide presents an orthogonal assay framework that separates VDR-dependent transcription, cell-state effects, and translational interpretation.

8662 records 1/578 page Next 12345 下5页 Last page